3rd Edition of Dementia World Conference (DWC) 2026

Speakers - DWC 2025

Christopher U Missling

  • Designation: Anavex Life Sciences
  • Country: USA

Biography

Christopher U Missling, PhD is President and CEO of Anavex Life Sciences, has over 20 years of healthcare industry experience within pharmaceutical and biotech industry. Prior to joining Anavex, he served as Officer at Curis and ImmunoGen and previously at Aventis (now Sanofi). Christopher’s work is dedicated to advancing potential treatments for Alzheimer’s disease as well as diseases, like autism-spectrum-disorder by utilizing precision medicine. Dr. Missling is working with his team to advance new potential treatments by involving the respective advocacy groups. Dr. Missling has an MS and PhD and an MBA from Northwestern University Kellogg School of Management.